A molecular study of the t(4;14) in multiple myeloma

British Journal of Haematology

Volumn 118, Issue 2, 2002, Pages 514-520

  Sibley, Kathryn ^a   Fenton, James A L ^a   Dring, Ann M ^a   Ashcroft, Andrew J ^a   Rawstron, Andrew C ^b   Morgan, Gareth J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

FGFR3; MMSET; Mutation; Myeloma; Translocation

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN; PHOSPHOTRANSFERASE;

ALTERNATIVE RNA SPLICING; ARTICLE; BINDING SITE; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 4; CONTROLLED STUDY; DISEASE COURSE; EXON; GENE DELETION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CARRIER PROTEINS; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 4; HIGH MOBILITY GROUP PROTEINS; HUMANS; MULTIPLE MYELOMA; MUTATION; PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECURRENCE; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 0036036768     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03618.x     Document Type: Article

References (24)

1. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies
2. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations
3. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
4. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
5. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts
6. Angiogenic factors in multiple myeloma: Higher levels in bone marrow than in peripheral blood
7. A new member of a hepatoma-derived growth factor gene family can translocate to the nucleus
8. Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14)
9. Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice
10. Novel transcripts of fibroblast growth factor receptor 3 reveal aberrant splicing and activation of cryptic splice sequences in colorectal cancer
11. Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas
12. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by reverse transcription-polymerase chain reaction analysis of IGH-MMSET fusion transcripts
13. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization
14. Receptor specificity of the fibroblast growth factor family
15. Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32.3) and FGFR3 translocation
16. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas
17. Clinical spectrum of fibroblast growth factor receptor mutations
18. Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis
19. A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene
20. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis
21. Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma
22. Identification of a new fibroblast growth factor receptor, FGFR5
23. Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas
24. Altered intracellular localization of fibroblast growth factor receptor 3 in human breast cancer